Table 1.
Patient characteristics (n = 42)
Number of patients | Prostate (n = 33) | Prostate bed (n = 9) | Total (n = 42) |
Age | |||
Mean | 67.2 | 59.63 | 65.5 |
Median [range] | 66.5 [56;77] | 62 [49;66] | 64 [49;77] |
OMS | |||
0 | 28 | 9 | 37 (88%) |
1 | 4 | 0 | 4 (10%) |
2 | 1 | 0 | 1 (2%) |
>2 | 0 | 0 | 0 |
Initial PSA (ng/ml) | |||
Median [range] | 12.9 [3;120] | 7.6 [5;15] | 10.1 [3;120] |
PSA nadir (ng/ml) | |||
Median [range] | 0.5 [0.01;1.8] | 0.6 [0.01;0.6] | 0.3 [0.01;1.8] |
Initial Gleason score | |||
6 | 8 | 2 | 10 (25%) |
7 | 17 | 6 | 23 (58%) |
8 | 4 | 1 | 5 (13%) |
9 | 2 | 0 | 2 (5%) |
Initial disease category: D’Amico group | |||
Low | 5 | 1 | 6 (16%) |
Intermediate | 10 | 5 | 15 (36%) |
High | 18 | 3 | 21 (48%) |
Initial treatment: | |||
ADT | 28 | 6 | 34 (84%) |
RT 3D | 26 | 9 | 35 (83%) |
RT IMRT | 2 | 0 | 5 (12%) |
brachytherapy | 2 | 0 | 2 (5%) |
Initial RT dose: | |||
Median [range] (months) | 74 [70;76] | 68 [65;70] | 74 [65;76] |
Interval between initial RT and reirradiation | |||
Median [range] (months) | 65 [29;204] | 128 [54;207] | 82.5 [29;207] |